These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 30670062)

  • 1. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
    J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
    Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
    J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
    Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
    Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
    J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
    Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
    Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
    Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
    Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
    Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
    Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
    Taylor DD; Gercel-Taylor C
    Gynecol Oncol; 2008 Jul; 110(1):13-21. PubMed ID: 18589210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
    Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
    Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W; Liu J; Zhang Q; Wei L
    Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exosomal
    Chen L; Wang K; Li L; Zheng B; Zhang Q; Zhang F; Chen J; Wang S
    Future Oncol; 2022 Aug; 18(26):2919-2931. PubMed ID: 35893704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.
    Meng X; Joosse SA; Müller V; Trillsch F; Milde-Langosch K; Mahner S; Geffken M; Pantel K; Schwarzenbach H
    Br J Cancer; 2015 Nov; 113(9):1358-66. PubMed ID: 26393886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma.
    Que R; Ding G; Chen J; Cao L
    World J Surg Oncol; 2013 Sep; 11():219. PubMed ID: 24007214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.